Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

By J. Hirsh, J. Dalen, D. Anderson, L. Poller, H. Bussey, J. Ansell, D. Deykin. Chest, 2001

1,780 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Internal Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/56daf3ca6b1941292f42de86843127a3c0b1a6ea

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. A. Turpie

In Internal Medicine

1. A. Turpie

Citations in the corpus

• Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008, background): “111 PT monitoring of warfarin treatment is not standardized when expressed in seconds, as a simple ratio of the patient’s plasma value to that of plasma from a healthy control subject, or as a percentage of diluted normal plasma.”
• Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. (2003, background): “0 per 100 patient-years among those assigned to low-intensity therapy, [6] an average of 2.”